Stocks › GH

Guardant Health, Inc.

GH·Nasdaq·United States United States·USD
$145.83
+0.24 (+0.16%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
GH
Guardant Health, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
GHS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of GH by members of U.S. Congress · 12 on record · 2 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Jonathan L. JacksonJonathan L. JacksonHouse · D · IL GHGuardant Health, Inc. · Stock Purchase
$15,001 - $50,000
Oct 19, 2026 Sep 28, 2026 Filing ↗
Sheldon WhitehouseSheldon WhitehouseSenate · D · RI GHGuardant Health, Inc. · Stock Purchase
$1,001 - $15,000
Dec 1, 2025 Nov 21, 2025 Filing ↗
Donald S. Beyer, Jr.Donald S. Beyer, Jr.House · D · VA GHGuardant Health, Inc. · Stock Sale
$1,001 - $15,000
Mar 3, 2022 Feb 28, 2022 Filing ↗
Donald S. Beyer, Jr.Donald S. Beyer, Jr.House · D · VA GHGuardant Health, Inc. · Stock Sale
$1,001 - $15,000
Feb 1, 2022 Jan 13, 2022 Filing ↗
Donald S. Beyer, Jr.Donald S. Beyer, Jr.House · D · VA GHGuardant Health, Inc. · Stock Sale
$1,001 - $15,000
Jan 1, 2022 Dec 22, 2021 Filing ↗
Donald S. Beyer, Jr.Donald S. Beyer, Jr.House · D · VA GHGuardant Health, Inc. · Stock Purchase
$1,001 - $15,000
Dec 1, 2020 Nov 2, 2020 Filing ↗
Donald S. Beyer, Jr.Donald S. Beyer, Jr.House · D · VA GHGuardant Health, Inc. · Stock Purchase
$1,001 - $15,000
Nov 5, 2020 Oct 5, 2020 Filing ↗
Donald S. Beyer, Jr.Donald S. Beyer, Jr.House · D · VA GHGuardant Health, Inc. · Stock Purchase
$1,001 - $15,000
Nov 5, 2020 Oct 22, 2020 Filing ↗
Donald S. Beyer, Jr.Donald S. Beyer, Jr.House · D · VA GHGuardant Health, Inc. · Stock Sale
$1,001 - $15,000
Aug 9, 2020 Jul 14, 2020 Filing ↗
Donald S. Beyer, Jr.Donald S. Beyer, Jr.House · D · VA GHGuardant Health, Inc. · Stock Sale
$1,001 - $15,000
May 31, 2020 May 1, 2020 Filing ↗
Donald S. Beyer, Jr.Donald S. Beyer, Jr.House · D · VA GHGuardant Health, Inc. · Stock Sale
$1,001 - $15,000
May 9, 2020 Apr 27, 2020 Filing ↗
Donald S. Beyer, Jr.Donald S. Beyer, Jr.House · D · VA GHGuardant Health, Inc. · Stock Purchase
$1,001 - $15,000
Feb 22, 2020 Feb 14, 2020 Filing ↗

Whale Activity

Position changes in GH reported for 2026-09-30 by 736 institutional filers
Increased: 244New: 132Held: 71Decreased: 201Closed: 59No prior filing: 29
  • Increased244
  • New132
  • Held71
  • Decreased201
  • Closed59
  • No prior filing29
FilerSharesValueChange
BlackRock, Inc.8.0M$1.43Bincreased
FMR LLC7.3M$1.31Bincreased
VANGUARD CAPITAL MANAGEMENT LLC5.8M$1.04Bincreased
PRICE T ROWE ASSOCIATES INC /MD/5.7M$1.02Bdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC5.3M$951.6Mdecreased
FRANKLIN TEMPLETON INC3.4M$571.8Mincreased
TWO SIGMA INVESTMENTS, LP3.1M$546.4Mdecreased
Invesco Ltd.3.0M$530.5Mdecreased
Capital International Investors2.9M$523.8Mdecreased
Deep Track Capital, LP2.8M$500.4Mdecreased
GOLDMAN SACHS GROUP INC2.8M$499.4Mdecreased
AMERIPRISE FINANCIAL INC2.7M$474.7M—

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by GH insiders, by quarter · Form 4
-1.0M-500.0K0500.0K1.0M2025 Q1: -3,9482025 Q12025 Q2: -260.2K2025 Q22025 Q3: -404.7K2025 Q32025 Q4: -378.7K2025 Q42026 Q1: -63.3K2026 Q12026 Q2: -721.5K2026 Q22026 Q3: -182.9K2026 Q32026 Q4: -4,2122026 Q4

Recent Insider Transactions

2,168 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Monroe Terilyn J.Chief People Officer Sale −704 $143.64 $101K Nov 18, 2026 Form 4 ↗
Monroe Terilyn J.Chief People Officer Sale −500 $140.64 $70K Nov 18, 2026 Form 4 ↗
Monroe Terilyn J.Chief People Officer Sale −1,338 $142.83 $191K Nov 18, 2026 Form 4 ↗
Monroe Terilyn J.Chief People Officer Sale −1,200 $141.79 $170K Nov 18, 2026 Form 4 ↗
Monroe Terilyn J.Chief People Officer Sale −100 $144.58 $14K Nov 18, 2026 Form 4 ↗
Tariq MusaDirector · Director Sale −116 $149.56 $17K Nov 16, 2026 Form 4 ↗
Azar Alex M IIDirector · Director Sale −69 $149.56 $10K Nov 16, 2026 Form 4 ↗
Tariq MusaDirector · Director Sale −116 $165.88 $19K Oct 16, 2026 Form 4 ↗
Azar Alex M IIDirector · Director Sale −69 $159.89 $11K Oct 14, 2026 Form 4 ↗
MIGNONE ROBERTODirector Option exercise +264 $0.00 $0 Sep 21, 2026 Form 4 ↗
Hidalgo Medina ManuelDirector Option exercise +232 $0.00 $0 Sep 17, 2026 Form 4 ↗
Tariq MusaDirector Sale −116 $175.00 $20K Sep 16, 2026 Form 4 ↗
Krognes Steve E.Director Sale −971 $177.48 $172K Sep 16, 2026 Form 4 ↗
Krognes Steve E.Director Sale −1,300 $176.34 $229K Sep 16, 2026 Form 4 ↗
Krognes Steve E.Director Sale −3,300 $175.42 $579K Sep 16, 2026 Form 4 ↗
Krognes Steve E.Director Sale −1,103 $174.46 $192K Sep 16, 2026 Form 4 ↗
Azar Alex M IIDirector Sale −826 $175.00 $145K Sep 16, 2026 Form 4 ↗
Chudova DaryaChief Technology Officer Sale −7,738 $178.00 $1.4M Sep 15, 2026 Form 4 ↗
Tariq MusaDirector Option exercise +249 $0.00 $0 Sep 15, 2026 Form 4 ↗
Azar Alex M IIDirector Option exercise +1,651 $0.00 $0 Sep 12, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding GH · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
4.0M$600.1M0.03%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
2.9M$433.4M0.23%Jun 30, 2026
T. Rowe Price New Horizons Fund, Inc.1.8M$266.8M1.81%Jun 30, 2026
Franklin Dynatech Fund
Franklin Custodian Funds
1.8M$262.6M0.87%Jun 30, 2026
FULLERTHALER BEHAVIORAL SMALL-CAP GROWTH
Capitol Series Trust
1.7M$259.5M4.20%Jun 30, 2026
VANGUARD SMALL-CAP GROWTH INDEX FUND
VANGUARD INDEX FUNDS
1.7M$249.9M0.53%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.5M$228.1M0.23%Jun 30, 2026
Eventide Gilead Fund
MUTUAL FUND SERIES TRUST
1.3M$189.8M5.52%Jun 30, 2026
Growth Fund of America1.1M$177.3M0.05%Aug 31, 2026
Invesco Discovery Fund
AIM Counselor Series Trust (Invesco Counselor Series Trust)
975.6K$155.1M2.09%Aug 31, 2026

Mutual funds and ETFs whose N-PORT filings list GH's shares (CUSIP 40131M109), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Abigail P. JohnsonSCHEDULE 13G · passive (13G) · 7.7M shares5.8%
    Nov 5, 2026 · ↗
  • FMR LLCSCHEDULE 13G · passive (13G) · 7.7M shares5.8%
    Nov 5, 2026 · ↗
  • T. Rowe Price Associates, Inc.SCHEDULE 13G/A · passive (13G) · 6.5M shares4.9%
    Aug 14, 2026 · ↗
  • BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 6.9M shares5.2%
    Jul 28, 2026 · ↗
  • T. Rowe Price Associates, Inc.SCHEDULE 13G · passive (13G) · 7.0M shares5.4%
    May 15, 2026 · ↗
  • Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 6.6M shares5.0%
    Apr 30, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming guardant health as client
$0$625K$1.3M$1.9M$2.5M2023 Q1: $367K2023 Q2: $355K2023 Q3: $355K2023 Q4: $355K20232024 Q1: $385K2024 Q2: $380K2024 Q3: $366K2024 Q4: $400K20242025 Q1: $347K2025 Q2: $447K2025 Q3: $417K2025 Q4: $867K20252026 Q1: $337K2026 Q2: $356K2026 Q3: $196K2026
  • TODD STRATEGY GROUPGUARDANT HEALTH, INC. · 2026 Q2 · HCR$80K
    Filing ↗
  • GUARDANT HEALTHGUARDANT HEALTH · 2026 Q3 · MMM, HCR$180K
    Filing ↗
  • IPOLICY SOLUTIONSGUARDANT HEALTH INC. · 2026 Q3 · MMM, MED$16K
    Filing ↗
  • TODD STRATEGY GROUPGUARDANT HEALTH, INC. · 2026 Q2 · HCR$80K
    Filing ↗
  • GUARDANT HEALTHGUARDANT HEALTH · 2026 Q2 · MMM, HCR$180K
    Filing ↗

Government Contracts

Federal awards to Guardant Health, Inc. · USAspending

No federal contract awards found for Guardant Health, Inc..

U.S. Patents

Recent USPTO applications naming Guardant Health, Inc.

No USPTO patent applications found for Guardant Health, Inc..

Annual Financials

From GH's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$982.0M$739.0M$563.9M$449.5M$373.7M
Operating income-$437.2M-$443.6M-$564.7M-$544.4M-$411.0M
Net income-$416.3M-$436.4M-$479.4M-$654.6M-$384.8M
Diluted EPS-$3.32-$3.56-$4.28-$6.41-$4.00
Operating cash flow-$184.8M-$239.9M-$325.0M-$309.5M-$209.0M
Cash and equivalents$378.2M$525.5M$1.13B$141.6M$492.2M
Total assets$2.01B$1.49B$1.79B$1.61B$2.20B
Total liabilities$2.11B$1.63B$1.63B$1.55B$1.56B
Shareholders' equity-$99.3M-$139.6M$158.7M$60.2M$645.0M

As Guardant Health, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 19, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in GH's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 1.01, 2.03, 3.02, 8.01, 9.01Material agreement · Direct financial obligation · Unregistered sale of equityNov 16, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsNov 5, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 9.01Officer / director changeNov 3, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 9.01Officer / director changeNov 3, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsJul 30, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 18, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
    EDGAR ↗

About Guardant Health, Inc.

From SEC EDGAR company records
Industry (SIC 8071)Services-Medical Laboratories
SectorHealthcare
HeadquartersPALO ALTO, CA
IncorporatedDE